Insulet Recalls Omnipod Pods Due to Insulin Leakage Risk
Insulet has recalled certain Omnipod Pods due to a defect that may cause insulin leakage.
Asset / Drug
Drug and asset intelligence for Insulet with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.